| Particulars |
|
|
|
| Company Name
| Sun Pharma Advanced Research Company Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
32.45 |
B.V. (₹) |
3.80 |
| Sales(₹ Cr.) |
75.55 |
NP (₹ Cr.) |
-388.69 |
| NP Var% |
-75.00 |
Div% |
0.00 |
| CPS(₹) |
-11.60 |
EPS (₹) |
-12.00 |
| Traded Value(₹ Lakhs) |
65.98 |
52 Week High |
474.00 |
| 52 Week Low |
109.00 |
Price BSE |
146.00 |
| Price NSE |
146.00 |
Market Capital (₹ Cr.) |
4,729.90 |
| P/C Ratio |
-12.60 |
P/E Ratio |
-12.20 |
| Price Vs.BV |
38.42 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
14.91 |
| NP(₹ Cr.) |
-79.71 |
NP Var % |
20.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
60.09 |
| OPM |
-680.83 |
NP |
-410.87 |
| NP Var% |
-7.57 |
EPS |
0.00 |
| PE |
0.00 |
|
|